Sarah Solomon

Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial

Suzanne George, Qian Wang, Michael C. Heinrich et al. · Journal of Clinical Oncology · 2012 · 245 citations · Full text

Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study

Eytan Ben‐Ami, Constance M. Barysauskas, Sarah Solomon et al. · Cancer · 2017 · 215 citations · Full text

Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard tyrosine kinase inhibitor therapy

Eytan Ben‐Ami, Constance M. Barysauskas, Margaret von Mehren et al. · Annals of Oncology · 2016 · 160 citations · Full text

Oncology, Gastrointestinal Oncology, Medicine +7

A multicenter phase II study of regorafenib in patients (pts) with advanced gastrointestinal stromal tumor (GIST), after therapy with imatinib (IM) and sunitinib (SU).

Suzanne George, Margaret von Mehren, Michael C. Heinrich et al. · Journal of Clinical Oncology · 2011 · 28 citations

Oncology, Gastrointestinal Oncology, Eligible Pts +14

Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype

Abel Suárez‐Fueyo, Sean J. Bradley, Takayuki Katsuyama et al. · The Journal of Immunology · 2018 · 19 citations · Full text